Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 years

European Journal of Cancer

Volumn 37, Issue 3, 2001, Pages 385-391

  Bergeron, C ^a   Iliescu, C ^a   Thiesse, P ^a   Bouvier, R ^b   Dijoud, F ^b   Ranchere Vince, D ^a   Basset, T ^b   Chappuis, J P ^b   Buclon, M ^a   Frappaz, D ^a   Brunat Mentigny, M ^a   Philip, T ^a  

^a CENTRE LÉON BÉRARD   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Chemotherapy; Children; Nephroblastomas; Nephroblastomatosis; Wilms' tumour

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WILMS TUMOR;

EID: 0035129674     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00409-3     Document Type: Article

References (32)

1. Tumors of the kidney, renal pelvis, and ureter
2. The nephroblastomatosis complex and its relationship to Wilms' tumor: A clinicopathologic treatise
3. Precursor lesions of Wilms tumor: Clinical and biological implications
4. Persistent renal blastema (nephroblastomatosis) as a frequent precursor of Wilms tumor: A pathological and clinical review Part 2: Significance of nephroblastomatosis in the genesis of Wilms' tumor
5. Persistent renal blastema (nephroblastomatosis) as a frequent precursor of Wilms tumor; a pathological and clinical review. Part 3: Clinical aspects of nephroblastomatosis
6. Nephrogenic rests, nephroblastomatosis and the pathogenesis of Wilms' tumor
7. Nephroblastomatosis and Wilms' tumor. Clinical experience and management of seven patients
8. US, CT and MR imaging characteristics of nephroblastomatosis
9. Malignant renal tumors of childhood
10. Wilms' tumor with pulmonary metastases at diagnosis: The significance of primary chemotherapy
11. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and study: A risk-adapted therapeutic approach in Wilms' tumor
12. Preoperative strategies in the management of Wilms tumor
13. Nonparametric estimation from incomplete observation
14. Evaluation of survival data and two new rank statistics arising in its consideration
15. Bilateral nephroblastomatosis in a premature infant
16. The treatment of Wilms tumor: Results of the National Wilms Tumor Studies
17. Renal salvage procedures in patients with synchronous bilateral Wilms' tumors: A report from the National Wilms' Tumor Study Group
18. Factors affecting the risk of contralateral Wilms tumor development
19. Extended follow-up of bilateral Wilms tumor: Results of the National Wilms Tumor Study
20. Metachronous bilateral Wilms' tumor: The importance of time interval to development of a second tumor
21. Massive infantile nephroblastomatosis: A clinical, radiological and pathological analysis of four cases
22. Bilateral, diffuse nephroblastomatosis: Report of a case managed with chemotherapy
23. Bilateral massive nephroblastomatosis in infancy
24. Induction and treatment of Wilms tumor by transplantation of renal blastema in a new experimental model
25. Bilateral nephroblastomatosis in a premature infant
26. Bilateral nephroblastomatosis and Klippel-Trenaunay syndrome
27. Treatment strategy for nodular renal blastema and nephroblastomatosis associated with Wilms' tumour
28. The nephroblastomatosis complex and its relationship to Wilms' tumour
29. Position paper: Imaging methods for primary renal tumors of childhood: Costs versus benefits
30. Children at increased risk for Wilms tumor: Monitoring issues
31. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: An analytical review
32. Growth rate of Wilms tumour